Nephron-Sparing Surgery for Adenocarcinoma in a Renal Allograft

The incidence of malignant tumors in recipients of renal allografts is higher than in the general population. Renal cell carcinoma (RCC) accounts for 4.6% of the tumors in transplanted patients; of them, only 10% are found in transplanted kidneys. Transplantectomy has always been the usual treatment...

Full description

Saved in:
Bibliographic Details
Main Authors: Fernando Vázquez Alonso, Enrique Cardozo Rodríguez, Ignacio Puche Sanz, Jose Francisco Flores Martin, Jose Miguel Molina Hernandez, Raquel Berrio Campos, Javier Vicente Prados, Antonio Medina Benitez, Jose Manuel Cózar Olmo
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Case Reports in Urology
Online Access:http://dx.doi.org/10.1155/2012/692986
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The incidence of malignant tumors in recipients of renal allografts is higher than in the general population. Renal cell carcinoma (RCC) accounts for 4.6% of the tumors in transplanted patients; of them, only 10% are found in transplanted kidneys. Transplantectomy has always been the usual treatment. However, during the last years, nephron-sparing surgery of the allograft is more frequently done in well-selected cases, and therefore dialysis can be avoided. We report the case of a 37-year-old female patient with renal transplant, diagnosed with a 4.5 cm tumor in the lower pole of the renal allograft. The patient underwent partial nephrectomy successfully. Six years after surgery, there is no evidence of recurrence of the disease and the patient maintains an adequate renal function.
ISSN:2090-696X
2090-6978